Global Central Lab Services Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets™

Asia Pacific to lead growth as pharmaceutical innovation and advanced analytics reshape clinical research

Delray Beach, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The global Central Lab Services Market, valued at US$5.64 billion in 2024, stood at US$5.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$8.18 billion by the end of the period. This growth is propelled by escalating research and development (R&D) investments, the increasing prevalence of rare diseases, and the rapid adoption of decentralized trial models that enhance patient access and data quality.

Central lab services form the backbone of modern clinical research, delivering standardized testing, data integrity, and regulatory compliance across multi-site trials. From biomarker analysis and genetic testing to microbiology and immunology, these services ensure consistent, accurate results—critical to advancing therapies from development to market approval.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106848348

Key Market Drivers
Rising R&D Investments:
Pharmaceutical and biotech companies are intensifying R&D spending to accelerate trial timelines and improve accuracy. Advancements in precision medicine, genomics, and proteomics require central labs equipped to process complex datasets rapidly. According to IQVIA, clinical development productivity reached a five-year high in 2023, with 69 novel active substances launched globally, including 24 first-in-class approvals in the US.

Decentralized Trial Expansion:
Virtual and decentralized clinical trials are transforming the Central Lab Services market by removing geographical barriers and boosting patient engagement. Industry leader IQVIA operates over 500 decentralized trial facilities across more than 75 countries, leveraging AI-powered analytics and remote monitoring for real-time decision-making and improved trial outcomes.

Market Challenges and Strategic Imperatives
A shortage of skilled professionals in advanced lab operations, regulatory compliance, and trial design continues to challenge the market. As of 2022, the US had approximately 342,900 clinical lab technicians and technologists—insufficient to meet rising demand. Addressing this gap will require investments in training, automation, and digital solutions.

Another priority is improving patient diversity in trials. Overcoming socio-economic, geographic, and cultural barriers is essential for ensuring data validity and regulatory acceptance, particularly as central labs support increasingly global trial networks.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=106848348

Segment and Regional Outlook

By Phase: Phase III dominates the Central Lab Services market in 2024 due to its large-scale participant requirements, regulatory scrutiny, and need for comprehensive biomarker and genomic testing.
By End User: Pharmaceutical and biopharmaceutical companies represent the largest client base, benefiting from scalable testing solutions that reduce onsite lab costs and streamline operations.
By Region: Asia Pacific is forecast to post the fastest CAGR, driven by expanding biopharma sectors in China, Japan, and India, and by the region’s diverse patient population which supports robust, multi-demographic trial data.

Key Industry Players
Market leaders include Thermo Fisher Scientific Inc. (US), IQVIA (US), and ICON plc (Ireland), recognized for their global reach, comprehensive service portfolios, and technological innovation. Notable developments include:

Thermo Fisher Scientific expanded its European testing capabilities in chromatography, flow cytometry, and molecular genomics (Oct 2024).
IQVIA introduced One Home for Sites, a platform streamlining trial site management (Jul 2024).
ICON plc partnered with BARDA to advance next-generation COVID-19 vaccine trials (Sep 2023).

Other prominent players include Labcorp, Quest Diagnostics, Charles River Laboratories, Eurofins Scientific, and Medpace.

Strategic Relevance for Executives
For C-suite leaders, the Central Lab Services market represents both an operational enabler and a competitive differentiator. Partnering with advanced, technology-enabled central labs can shorten drug development cycles, lower costs, and meet evolving regulatory expectations. The convergence of AI-driven analytics, decentralized trial designs, and global patient engagement positions the sector for sustained, high-value growth.

For more information, Inquire Now!

Discover Connected Healthcare Market Opportunities:
Clinical Trial Supplies Market
Clinical Trial Imaging Market
Clinical Microbiology Market
Companion Diagnostics Market
Clinical Trial Services Market

Get access to the latest updates on Top Companies in Central Lab Services and Central Lab Services Market Size

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445,
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: www.marketsandmarkets.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.